hmr 1766 has been researched along with bay 58-2667 in 2 studies
| Studies (hmr 1766) | Trials (hmr 1766) | Recent Studies (post-2010) (hmr 1766) | Studies (bay 58-2667) | Trials (bay 58-2667) | Recent Studies (post-2010) (bay 58-2667) |
|---|---|---|---|---|---|
| 23 | 1 | 11 | 104 | 6 | 69 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmidt, HH; Schmidt, PM; Stasch, JP | 1 |
| Hoffmann, LS; Keim, Y; Schaefer, S; Schmidt, HH; Schmidt, PM; Stasch, JP | 1 |
1 review(s) available for hmr 1766 and bay 58-2667
| Article | Year |
|---|---|
NO- and haem-independent soluble guanylate cyclase activators.
Topics: Animals; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Drug Delivery Systems; Enzyme Activators; Guanylate Cyclase; Heme; Humans; Nitric Oxide; ortho-Aminobenzoates; Oxidative Stress; Receptors, Cytoplasmic and Nuclear; Risk Factors; Soluble Guanylyl Cyclase; Sulfonamides | 2009 |
1 other study(ies) available for hmr 1766 and bay 58-2667
| Article | Year |
|---|---|
Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
Topics: Aequorin; Animals; Benzoates; Binding Sites; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activation; Enzyme Activators; Enzyme Inhibitors; Enzyme Stability; Genes, Reporter; Guanylate Cyclase; Heme; Molecular Structure; Mutation; ortho-Aminobenzoates; Oxadiazoles; Oxidation-Reduction; Protoporphyrins; Pyrazoles; Pyridines; Quinoxalines; Rats; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Structure-Activity Relationship; Sulfonamides; Swine; Transfection | 2009 |